Sarizotan in Parkinson Patients With L-dopa-induced Dyskinesia

Summary

The primary purpose of the study is to investigate the anti-dyskinetic effect of several doses of sarizotan in Parkinson patients in order to generate information on the dose-response relationship (dose-finding).

Timeline

Start

2002-07

Primary completion

—

Completion

2003-07

Drugs

Indications